BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 26231704)

  • 1. Expression and Purification of Recombinant Cyclins and CDKs for Activity Evaluation.
    Gallastegui E; Bachs O
    Methods Mol Biol; 2016; 1336():9-12. PubMed ID: 26231704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoprecipitation of Cdk-Cyclin Complexes for Determination of Kinase Activity.
    Gallastegui E; Bachs O
    Methods Mol Biol; 2016; 1336():1-8. PubMed ID: 26231703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cell cycle kinases.
    Pines J
    Semin Cancer Biol; 1994 Aug; 5(4):305-13. PubMed ID: 7803767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors.
    Pavletich NP
    J Mol Biol; 1999 Apr; 287(5):821-8. PubMed ID: 10222191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical inhibitors of cyclin-dependent kinases.
    Meijer L; Kim SH
    Methods Enzymol; 1997; 283():113-28. PubMed ID: 9251015
    [No Abstract]   [Full Text] [Related]  

  • 6. Expression and Purification of Recombinant CDKs: CDK7, CDK8, and CDK9.
    Pinhero R; Yankulov K
    Methods Mol Biol; 2016; 1336():13-28. PubMed ID: 26231705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of recombinant cyclin B1/cdc2 kinase from Xenopus egg extracts.
    Wilhelm H; Andersen SS; Karsenti E
    Methods Enzymol; 1997; 283():12-28. PubMed ID: 9251008
    [No Abstract]   [Full Text] [Related]  

  • 8. Purification and reconstitution of cyclin-dependent kinase 2 in four states of activity.
    Russo AA
    Methods Enzymol; 1997; 283():3-12. PubMed ID: 9251007
    [No Abstract]   [Full Text] [Related]  

  • 9. Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms.
    Satyanarayana A; Kaldis P
    Oncogene; 2009 Aug; 28(33):2925-39. PubMed ID: 19561645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of plant cyclin-dependent kinase activity using immunoprecipitation-coupled and affinity purification-based kinase assays and the baculovirus expression system.
    Harashima H; Sekine M
    Methods Mol Biol; 2011; 779():65-78. PubMed ID: 21837561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDK activation by non-cyclin proteins.
    Nebreda AR
    Curr Opin Cell Biol; 2006 Apr; 18(2):192-8. PubMed ID: 16488127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and crystallization of cyclin-dependent kinase inhibitor p21.
    Mayrose DR; Nichols MA; Xiong Y; Ke H
    Protein Sci; 1996 Sep; 5(9):1928-30. PubMed ID: 8880918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit.
    Gu Y; Turck CW; Morgan DO
    Nature; 1993 Dec; 366(6456):707-10. PubMed ID: 8259216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the interactions between human cdc25C, cdks, cyclins and cdk-cyclin complexes.
    Morris MC; Divita G
    J Mol Biol; 1999 Feb; 286(2):475-87. PubMed ID: 9973565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells.
    Sweeney KJ; Sarcevic B; Sutherland RL; Musgrove EA
    Oncogene; 1997 Mar; 14(11):1329-40. PubMed ID: 9178893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP-noncompetitive inhibitors of CDK-cyclin complexes.
    Orzáez M; Gortat A; Mondragón L; Bachs O; Pérez-Payá E
    ChemMedChem; 2009 Jan; 4(1):19-24. PubMed ID: 19039815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal Models for Studying the In Vivo Functions of Cell Cycle CDKs.
    Risal S; Adhikari D; Liu K
    Methods Mol Biol; 2016; 1336():155-66. PubMed ID: 26231715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E1A modulates phosphorylation of p130 and p107 by differentially regulating the activity of G1/S cyclin/CDK complexes.
    Parreño M; Garriga J; Limón A; Albrecht JH; Graña X
    Oncogene; 2001 Aug; 20(35):4793-806. PubMed ID: 11521191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cyclin-dependent kinase inhibitors in mammal cells].
    Jiang H; Wang YC
    Sheng Li Ke Xue Jin Zhan; 1996 Apr; 27(2):107-12. PubMed ID: 9592231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.